Session 3: US Health Science & Politics
A Path to Renewal of America’s Global Role in Health Science Policy
Oct 21, 2008 | Innovation 2008
http://www.viddler.com/explore/sciencedebate/videos/16/
Panelists
- Andrew Fire, Professor of Pathology and Genetics, Stanford University; Nobel Prize in Physiology or Medicine, 2006
- Michael T. Osterholm,
Director, Center for Infectious Disease Research and Policy (CIDRAP)
Director, Minnesota Center of Excellence for Influenza Research and
Surveillance (MCEIRS)
- Stacie Propst, Vice President of Science and Policy Outreach, Research!America
- Susan Wood,
Research Professor, School of Public Health and Health Services, George
Washington University School of Public Health and Health Services
(Former Asst. Commissioner for Women’s Health for FDA)
Moderator
- Jennifer Kuzma, Associate Professor, Hubert H. Humphrey School of Public Affairs, University of Minnesota
Health sciences research from cancer to stem cells to genetics has gone
global. Academic and industry leaders explore paths the new U.S.
Administration can take to compete in this new global landscape and
renew American innovation and leadership in the health sciences.
http://www.viddler.com/explore/sciencedebate/videos/16/
- Andrew Fire, Professor of Pathology and Genetics, Stanford University; Nobel Prize in Physiology or Medicine, 2006
- Michael T. Osterholm, Director, Center for Infectious Disease Research and Policy (CIDRAP) Director, Minnesota Center of Excellence for Influenza Research and Surveillance (MCEIRS)
- Stacie Propst, Vice President of Science and Policy Outreach, Research!America
- Susan Wood, Research Professor, School of Public Health and Health Services, George Washington University School of Public Health and Health Services (Former Asst. Commissioner for Women’s Health for FDA)
- Jennifer Kuzma, Associate Professor, Hubert H. Humphrey School of Public Affairs, University of Minnesota
Health sciences research from cancer to stem cells to genetics has gone global. Academic and industry leaders explore paths the new U.S. Administration can take to compete in this new global landscape and renew American innovation and leadership in the health sciences.